Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/35712
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Extending the horizon in chronic heart failure: Effects of multidisciplinary, home-based intervention relative to usual care |
Author: | Inglis, S. Pearson, S. Treen, S. Gallasch, T. Horowitz, J. Stewart, S. |
Citation: | Circulation, 2006; 114(23):2466-2473 |
Publisher: | Lippincott Williams & Wilkins |
Issue Date: | 2006 |
ISSN: | 0009-7322 1524-4539 |
Statement of Responsibility: | Sally C. Inglis, Sue Pearson, Suzette Treen, Tamara Gallasch, John D. Horowitz, Simon Stewart |
Abstract: | Background - The long-term impact of chronic heart failure management programs over the typical life span of affected individuals is unknown. Methods and Results - The effects of a nurse-led, multidisciplinary, home-based intervention (HBI) in a typically elderly cohort of patients with chronic heart failure initially randomized to either HBI (n=149) or usual postdischarge care (UC) (n=148) after a short-term hospitalization were studied for up to 10 years of follow-up (minimum 7.5 years of follow-up). Study end points were all-cause mortality, event-free survival (event was defined as death or unplanned hospitalization), recurrent hospital stay, and cost per life-year gained. Median survival in the HBI cohort was almost twice that of UC (40 versus 22 months; P<0.001), with fewer deaths overall (HBI, 77% versus 89%; adjusted relative risk, 0.74; 95% CI, 0.53 to 0.80; P<0.001). HBI was associated with prolonged event-free survival (median, 7 versus 4 months; P<0.01). HBI patients had more unplanned readmissions (560 versus 550) but took 7 years to overtake UC; the rates of readmission (2.04±3.23 versus 3.66±7.62 admissions; P<0.05) and related hospital stay (14.8±23.0 versus 28.4±53.4 days per patient per year; P<0.05) were significantly lower in the HBI group. HBI was associated with 120 more life-years per 100 patients treated compared with UC (405 versus 285 years) at a cost of $1729 per additional life-year gained when we accounted for healthcare costs including the HBI. Conclusions - In altering the natural history of chronic heart failure relative to UC (via prolonged survival and reduced frequency of recurrent hospitalization), HBI is a remarkably cost- and time-effective strategy over the longer term. |
Keywords: | cost-benefit analysis heart failure prevention prognosis |
Description: | © 2006 American Heart Association, Inc. |
DOI: | 10.1161/CIRCULATIONAHA.106.638122 |
Published version: | http://dx.doi.org/10.1161/circulationaha.106.638122 |
Appears in Collections: | Aurora harvest 6 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.